SEBRA Sepsis and Bacterial Resistance Alliance

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Infectious Medicine


Sepsis is a severe, systemic response to infection, often caused by bacteria. Approx. 30 million cases occur worldwide each year causing up to 8 million deaths. The mortality is as high as 30%. Rapid and accurate diagnosis is crucial, as mortality increases with 8% every hour that appropriate treatment is delayed. Sepsis is fairly unknown to the general public, and complicated by its rapid progression and diverse etiology. Furthermore, sepsis research is underfunded in comparison to other medical conditions.


SEpsis and Bacterial Resistance Alliance (SEBRA) is an awarded cross-professional interdisciplinary group of researchers and clinicians who represent the county hospital SUS Lund, and the Faculties of Medicine and Engineering (LTH) at Lund University. SEBRA’s aims are • To improve the basic knowledge of the underlying molecular mechanisms of sepsis • To identify molecular processes to enable improvement of sepsis diagnostics and treatment • To increase awareness of sepsis • To achieve a better coordination of sepsis research regionally and nationally.

Recent research outputs

Fredrik Kahn, Jonas Tverring, Lisa Mellhammar, Nils Wetterberg, Anna Bläckberg, Studahl, E., Hadorn, N., Robin Kahn, Nueesch, S., Jent, P., Ricklin, M. E., Boyd, J., Bertil Christensson, Sendi, P., Per Åkesson & Adam Linder, 2019 Feb 19, In : Shock.

Research output: Contribution to journalArticle

Hauri, S., Khakzad, H., Lotta Happonen, Teleman, J., Johan Malmström & Lars Malmström, 2019 Jan 14, In : Nature Communications. 10, 192.

Research output: Contribution to journalArticle

View All (44)